GlassScriptPhysician profile
Ryan P Kunkel
NPI 1144648627
$42,742.88
in general payments reported to CMS, 2019-2025
29 companies · $4,504 in 2025
The $4,504 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,691 · 2021: $32K · 2022: $1,380 · 2023: $799 · 2024: $2,568 · 2025: $4,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,917 · Honoraria: $2,400 · Travel and Lodging: $1,343 · Long Term Medical Supply Or Device Loan: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,916.88 |
| Honoraria | $2,400.00 |
| Travel and Lodging | $1,342.83 |
| Long Term Medical Supply Or Device Loan | $211.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $30,099.00 | 2021 | |
| Allergan, INC. | $3,452.53 | 2019-2022 | |
| Rti Surgical, INC | $3,273.47 | 2022-2025 | |
| Tela Bio, INC. | $1,388.74 | 2022-2024 | Ovitex 2s |
| Biocomposites INC | $1,005.58 | 2024-2025 | Stimulan |
| Abbvie INC. | $958.98 | 2023-2025 | |
| Kerecis Limited | $585.97 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Merz North America, INC. | $536.88 | 2022 | |
| Integra Lifesciences Corporation | $433.63 | 2021-2024 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Mentor Worldwide LLC | $257.63 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Galderma Laboratories, L.P. | $148.54 | 2022 | |
| Janssen Biotech, INC. | $103.96 | 2024-2025 | Tecvayli, Darzalex, Rybrevant |
| Ossio INC | $81.81 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $61.02 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $51.95 | 2024-2025 | Lynparza, Tagrisso, Calquence |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $33.52 | 2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $32.38 | 2024-2025 | |
| Puma Biotechnology, INC. | $29.19 | 2025 | |
| Coopersurgical, INC. | $26.86 | 2025 | Onetrac Lx |
| Aveo Pharmaceuticals, INC. | $25.12 | 2025 | |
| Exelixis INC. | $20.62 | 2025 | Cabometyx |
| Takeda Pharmaceuticals U.S.A., INC. | $20.18 | 2025 | Alunbrig |
| Merck Sharp & Dohme LLC | $19.33 | 2024 | Lynparza |
| Genentech USA, INC. | $17.72 | 2024 | Perjeta, Phesgo |
| Incyte Corporation | $17.64 | 2025 | Monjuvi, Zynyz |
| Seagen INC. | $17.56 | 2023 | Adcetris |
| Eisai INC. | $15.56 | 2023 | |
| Mindray Ds USA, INC. | $14.41 | 2024 | Te X, Te7 Max |
| Taiho Oncology, INC. | $13.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kunkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.